Ovid Therapeutics Inc. · NASDAQ:OVID
Point72 Asset Management, L.P. reported a 5.10% stake in Ovid Therapeutics Inc. (Schedule 13G)
Event Jan 2, 2026 · Filed Jan 5, 2026
Point72 Asset Management, L.P. reported a 5.10% stake in Ovid Therapeutics Inc., 6,727,209 shares, as a passive investor on Jan 2, 2026. Filed Jan 5, 2026 (Schedule 13G).
- Stake
- 5.10%
- Shares
- 6,727,209
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 3 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Point72 Asset Management, L.P. | 5.10% | 6,727,209 |
| Point72 Capital Advisors, Inc. | 5.10% | 6,727,209 |
| Steven A. Cohen | 5.10% | 6,727,209 |
Source
Related
- Ovid Therapeutics Inc.
- Point72 Asset Management, L.P.
- Ovid Therapeutics Inc. shareholders
- Schedule 13G/A · Point72 Asset Management, L.P. · May 15, 2026
- Schedule 13G/A · Eventide Asset Management, LLC · Aug 14, 2026
- Schedule 13G/A · Ra Capital Management, L.P. · Aug 14, 2026
- Schedule 13G/A · ADAR1 Capital Management, LLC · Aug 14, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G/A · Affinity Asset Advisors, LLC · Aug 13, 2026